US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist

20.280
+0.650+3.31%

Close Feb 28 16:00 ET

20.210
-0.070-0.35%

Post 20:01 ET

1.47BMarket Cap-33.80P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International Q4 2024 Earnings Date

Currency：USDFeb 25, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	123.38M	122.54M	-840.80K
Miss Est.	+47.94%	+46.93%	-0.68%
EPS	-<0.01	-0.12	-0.12
Miss Est.	-100.51%	-134.29%	-6566.67%

Analyst Rating

Strong Buy

Feb 28, 2025

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 141.938M	--
--	2025/Q1	-- / 129.872M	--
Feb 25, 2025	2024/Q4	122.536M / 123.377M	--
Oct 29, 2024	2024/Q3	112.214M / 111.599M	--
Jul 23, 2024	2024/Q2	108.631M / 91.266M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 141.938M--

--2025/Q1-- / 129.872M--

Feb 25, 20252024/Q4122.536M / 123.377M--

Oct 29, 20242024/Q3112.214M / 111.599M--

Jul 23, 20242024/Q2108.631M / 91.266M--

Unlock Free Earnings Estimates

Open Account

Kiniksa Pharmaceuticals International Earnings Reports

Kiniksa Pharmaceuticals International | 10-K: FY2024 Annual Report

Feb 25 16:21 ET

Kiniksa Pharmaceuticals International | 8-K: Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

Feb 25 07:36 ET

Kiniksa Pharmaceuticals International | 10-Q: Q3 2024 Earnings Report

Oct 29, 2024 16:21 ET

Kiniksa Pharmaceuticals International | 8-K: Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Oct 29, 2024 07:33 ET